Erin McEvoy

A recent study of a psychedelic compound found in ayahuasca produced new brain scans showing its impacts on the brain.

How much does hemp live up to its advertised potential as a versatile, sustainable crop and what is blocking its path to realizing its full abilities?

The Nova Scotia House of Assembly recently heard a petition to cover the cost of CBD-based medications for certain conditions.

To help clinicians and patients navigate cannabinoid-based medications (CBM), Cannabis and Cannabinoid Research published guidelines based on reviews of studies on CBM and chronic pain.

Recent reports on jobs and banking reveal the latest changes affecting the cannabis industry.

Two Colorado-based hemp companies and one tobacco company are joining forces to pursue FDA-approval for a new botanical drug.

The field of cannabis horticulture is ever-evolving and offers many opportunities for innovation and experimentation. In this interview, Jessica Lubell-Brand, PhD, professor of horticulture at the University of Connecticut with the Department of Plant Science and Landscape Architecture provides insights into the findings of her laboratory’s recent studies of the “retipping” method of propagating cannabis. She also shares details on her current research with cannabis breeding techniques and how studies like these can benefit the future of cannabis growing.

Let's hear what analytical track program chair Julie Kowalski is most excited about at Cannabis Science Conference Spring 2023!

In April 2023, two cannabis testing laboratories launched a certification program to promote higher standards for cannabis testing laboratories across the country.

Bipartisan legislation was recently reintroduced to remove barriers preventing veterans accessing medical cannabis as recommended by health care providers at the VA.

A pharmaceutical company, Vantage Hemp Co., announced it recently submitted two Drug Master Files (DMFs) to the Food and Drug Administration.

One recently published study suggests that a cannabis sublingual spray may be beneficial in the treatment of type 2 diabetes.

What is Cherissa Jackson, RN most excited about as the medical track program chair for Cannabis Science Conference?

A recently published case study documents one chronic pain patient’s reduction of prescribed pain medication after being referred to a medical cannabis registry. Prescribed cannabis-based medicinal products (CBMPs) have been legal in the UK since 2018.

Oregon Psilocybin Services (OPS) issued first psilocybin manufacturer license since accepting applications earlier this year.

Read an interview from Pharmaceutical Technology Europe exploring how the European bio/pharma industry’s high regulatory standards and GMP requirements are set to position the region as a frontrunner for pharmaceutical grade manufacturing of cannabis-based medicines.

Initial findings from a recent study suggested that cannabidiol (CBD) derivatives made naloxone treatment more effective, even against the opioid fentanyl.

The study will examine consumption and health of the participants after purchasing selected cannabis products from controlled cultivation under regulated conditions.

In late March, the Wine & Spirits Wholesalers of America submitted a letter to congressional leadership expressing its support for cannabis legalization that uses regulatory frameworks similar to those of the alcohol industry.

The Food and Drug Administration (FDA) will hold an educational webinar on cannabis and cannabis-derived products for healthcare practitioners in late March.

Health and safety notices were issued in two states due to concerns about contamination exposure.

In late March the Pennsylvania Commonwealth Court ruled that workers’ compensation must cover the cost of medical cannabis for treatment of injuries suffered on the job.

Hear a Noid Factoid from our latest podcast guest!

The owner and two biologists at Royal Queen Seeds recently presented their F1 hybrid process and strains in Barcelona, Spain.

A pioneer in global cannabis research, Professor Raphael Mechoulam died March 9th, 2023 in Israel at the age of 92.

A pioneer in global cannabis research, Professor Raphael Mechoulam died March 9th, 2023 in Israel at the age of 92.

The 2023 Portland show will include four tracks–analytical science, medical cannabis, cultivation, psychedelics–plus a discussion on medical cannabis for veterans, and more!

In early March 2023, the US Justice Department launched an online application for individuals who were pardoned for simple possession of cannabis under President Biden's October 6, 2022 proclamation. Applicants can now receive a certificate of proof of their pardon.

If passed into law, SB 1466 would reduce cost of renewing a medical cannabis card in Arizona, among other changes. The bill passed the senate with bipartisan approval 24 to 6 on March 2, 2023 (1).

A civil lawsuit filed in Arkansas by a medical cannabis patient alleges that three cannabis growers and one testing laboratory inflated the amount of tetrahydrocannabinol (THC) in numerous cannabis products.